Neoplex TM COVID-19 Detection kit

 

 

The NeoplexTM COVID-19 Detection kit  (ref. 9246) is designed according to the international CDC (Center for Disease Control and Prevention) guidelines for a correct detection of the COVID-19 viral RNA from naso-oropharyngeal swabs.


Most important characteristics:
 

  • CE-IVD and FDA-EUA marked
  • One unique one-step reaction Mastermix, ready to use
  • Simultaneous identification of both 2019-nCoV RdRp gene and the N gene, specific for the Betacoronavirus
  • Multiplex endogenous internal control
  • Software for the interpretation of results (upon demand)
  • Reaction positive control
  • 96 tests format
  • 1 year stability
  • Starting sample: nasal and oropharyngeal swabs, BAL, spit
  • 90 min reaction time
  • Validated platforms:
    • Thermo Fisher Scientific ABI 7500 (Fast) 
    • Thermo Fisher Scientific Quantstudio 5
    • Bio-Rad CFX96
    • Roche LightCycler 480 System I, II
    • Qiagen RotorGene Q (5plex)
    • Agilent AriaDx or AriaMx
    • Tianlong Gentier96 

 


Eurospital Spa - Via Flavia 122 - 34147 Trieste - P.IVA: 00047510326 - C.S. € 2582000 CF e Reg. Impr. 00047510326 - REA TS 38955
Eurospital © 2024 - Privacy - Site credits